Determination of preparation parameters for albendazole-loaded nanoparticles using chitosan and tripolyphosphate

Journal of Pharmaceutical Investigation

Volumn 45, Issue 3, 2015, Pages 265-269

  Kang, Bong Seok ^a   Lee, Sang Eun ^a   Ng, Choon Lian ^a   Cho, Cheong Weon ^a   Park, Jeong Sook ^a  

^a Chungnam National University   (South Korea)

Author keywords

Ablendazole; Anti cancer effect; Chitosan; Nanoparticle; Tripolyphosphate

Indexed keywords

ALBENDAZOLE; CHITOSAN; NANOPARTICLE; POLYSORBATE 20; TRIPOLYPHOSPHATE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CELL VIABILITY; CYTOTOXICITY; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG FORMULATION; DRUG SOLUBILITY; DRUG STABILITY; FILTRATION; HEPATOCELLULAR CARCINOMA CELL LINE; HUMAN; HUMAN CELL; MEDICAL DECISION MAKING; MTT ASSAY; NEOPLASM; PARTICLE SIZE; PRIORITY JOURNAL; PROCESS OPTIMIZATION;

EID: 84929082298     PISSN: 20935552     EISSN: 20936214     Source Type: Journal    
DOI: 10.1007/s40005-015-0171-6     Document Type: Article

References (23)

1. Anitha A, Deepa N, Chennazhi KP, Nair SV, Tamura H, Jayakumer R (2011) Development of mucoadhesive thiolated chitosan nanoparticles for biomedical applications. Carbohydr Polym 83:66–73
2. Baldrick P (2010) The safety of chitosan as a pharmaceutical excipient. Regul Toxicol Pharmcol 56:290–299
3. Barrera MG, Leonardi D, Bolmaro RE, Echenique CG, Olivieri AC, Salomon CJ, Lamas MC (2010) In vivo evaluation of albendazole microspheres for the treatment of Toxocara canis larva migrans. Eur J Pharm Biopharm 75:451–454
4. Castro SG, Sanchez Bruni SF, Urbizu LP, Confalonieri A, Ceballos L, Lanusse CE, Allemandi DA, Palma SD (2013) Enhanced dissolution and systemic availability of albendazole formulated as solid dispersions. Pharm Dev Technol 18:434–442
5. Cook GC (1990) Use of benzimidazole chemotherapy in human helminthiases: indication and efficacy. Parasitol Today (Regul Ed). 6:133–136
6. Dvorožňková E, Hrčková G, Borošková Z, Velebný S, Dubinský P (2004) Effect of treatment with free and liposomized albendazole on selected immunological parameters and cyst growth in mice infected with Echinococcus multilocularis. Parasitol Int 53:315–325
7. Evrard B, Chiap P, DeTullio P, Ghalmi F, Piel G, Van Hees T, Crommen J, Losson B, Delattre L (2002) Oral bioavailability in sheep of albendazole from a suspension and from a solution containing hydroxypropyl-beta-cyclodextrin. J Control Release 85:45–50
8. Fàbregas A, Miñarro M, García-Montoya E, Pérez-Lozano P, Carrillo C, Sarrate R, Sánchez N, Ticó JR, Suñé-Negre JM (2013) Impact of physical parameters on particle size and reaction yield when using the ionic gelation method to obtain cationic polymeric chitosan-tripolyphosphate nanoparticles. Int J Pharm 446:199–204
9. Gan Q, Wang T, Cochrane C, McCarron P (2005) Modulation of surface charge, particle size and morphological properties of chitosan-TPP nanoparticles intended for gene delivery. Colloids surf B 44:65–73
10. García JJ, Bolás F, Torrado JJ (2003) Bioavailability and efficacy characteristics of two different oral liquid formulations of albendazole. Int J Pharm 250:351–358
11. Gupta BP, Thakur N, Jain NP, Banweer J, Jain S (2010) Osmotically comtrolled drug delivry system with associated drugs. J Pharm Pharm Sci 13:571–588
12. Harun K, Mistafa M, Alisa S (2013) Effect of particle size on the dissolution of glibenclamide. Int J Pharm Pharm Sci 5:775–779
13. Jung H, Medina L, García L, Fuentes I, Moreno-Esparza T (1998) Absorption studies of albendazole and some physicochemical properties of the drug and its metabolite albendazole sulphoxide. J Pharm Pharmacol 50:43–48
14. Liu Y, Wang CQ, Ren WX, Chen YL, Yu Y, Zhang JK, Bawudong D, Gu JP, Xu XD, Zhang XN (2013) Novel albendazole-chitosan nanoparticles for intestinal absorption enhancement and hepatic targeting improvement in rats. J Biomed Mater Res B Appl Biomater 101:998–1005
15. Morris GA, Castile J, Smith A, Adams GG, Harding SE (2011) The effect of prolonged storage at different temperatures on the particle size distribution of tripolyphosphate (TPP)-chitosan nanoparticles. Carbohyd Polym 84:1430–1434
16. Nasti A, Zaki NM, De Leonaridis P, Ungphaiboon S, Rimoli MG, Tirelli N (2009) Chitosan/TPP and chitosan/TPP-hyaluronic acid nanoparticles: systematic optimization of the preparative process and preliminary biological evaluation. Pharm Res 26:1918–1930
17. Shekunov BY, Chattopadhyay P, Tong HHY, Chow AHHL (2007) Particle size analysis in pharmaceutics: principles, methods and applications. Pharm Res 24:203–227
18. Tsai ML, Bai SW, Chen RH (2008) Cavitation effects versus stretch effects resulted in different size and polydispersity of ionotropic gelation chitosan-sodium tripolyphosphate nanoparticle. Carbohydr Polym 71:448–457
19. Tsai ML, Chen RH, Bai SW, Chen WY (2011) The storage stability of chitosan/tripolyphosphate nanoparticles in a phosphate buffer. Carbohydr Polym 84:756–761
20. Vila A, Sánchez A, Tobiĭo M, Calvo P, Alonso MJ (2002) Design of biodegradable particle for protein delivery. J Control Release 78:15–24
21. Vogt M, Kunath K, Dressman JB (2008) Dissolution improvement of four poorly water soluble drugs by cogrinding with commonly used excipients. Eur J Pharm Biopharm 68:330–337
22. Zhang H, Oh M, Allen C, Kumacheva E (2004) Monodisperse chitosan nanoparticles for mucosal drug delivery. Biomacromolecules 5:2461–2468
23. Zhang XN, Gong JH, Tang LH, Zhang Q (2008) Studies on the drug-loading mechanism of polybutylcyanocrylate nanoparticle and its stability of thermodynamics. Curr Nanosci 4:59–61